Trials / Unknown
UnknownNCT02693340
Evolution of Lymphocyte Populations Under Biotherapy in Inflammatory Bowel Disease
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Assistance Publique - Hôpitaux de Paris · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a monocentric prospective study for the collection of biological samples (blood and biopsies) to be used for in vitro biomarker assay(s) performed to identify predictive markers of response to biological treatments in inflammatory bowel disease (IBD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | sampling | • Sampling period(s): * Blood: W0, W6, W14, W30 and W52 and relapse. * Biopsies and fecal: W0, W14 and M52 and relapse. |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2018-03-01
- Completion
- 2020-03-01
- First posted
- 2016-02-26
- Last updated
- 2016-06-24
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02693340. Inclusion in this directory is not an endorsement.